The expanding role of pertuzumab in the treatment of HER2-positive breast cancer
I Moya-Horno,1 J Cortés1,2 1Department of Medical Oncology, Instituto Oncológico Baselga, Hospital Quirón, 2Department of Medical Oncology, Vall d'Hebron Institute of Oncology, Barcelona, Spain Abstract: Breast cancer tumors that demonstrate gene amplificatio...
Saved in:
Main Authors: | Moya-Horno I, Cortés J |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2015
|
Subjects: | |
Online Access: | https://doaj.org/article/4330ba2b64314281afb0b2ecbad96dc8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of pertuzumab in the treatment of HER2-positive breast cancer
by: Hubalek M, et al.
Published: (2012) -
Neratinib plus trastuzumab is superior to pertuzumab plus trastuzumab in HER2-positive breast cancer xenograft models
by: Jamunarani Veeraraghavan, et al.
Published: (2021) -
Combination of Pertuzumab and Trastuzumab in the Treatment of HER2-Positive Early Breast Cancer: A Review of the Emerging Clinical Data
by: Jagosky M, et al.
Published: (2021) -
Role of trastuzumab emtansine in the treatment of HER2-positive breast cancer
by: Oostra DR, et al.
Published: (2014) -
Role of lapatinib alone or in combination in the treatment of HER2-positive breast cancer
by: Hurvitz SA, et al.
Published: (2012)